Jooss K - Search Results

1

Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver.

Jooss K, Ertl HC, Wilson JM. Jooss K, et al. J Virol. 1998 Apr;72(4):2945-54. doi: 10.1128/JVI.72.4.2945-2954.1998. J Virol. 1998. PMID: 9525615 Free PMC article.

2

Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM. Yang Y, et al. Among authors: jooss ku. Gene Ther. 1996 Feb;3(2):137-44. Gene Ther. 1996. PMID: 8867861

3

Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene.

Kozarsky KF, Jooss K, Donahee M, Strauss JF 3rd, Wilson JM. Kozarsky KF, et al. Among authors: jooss k. Nat Genet. 1996 May;13(1):54-62. doi: 10.1038/ng0596-54. Nat Genet. 1996. PMID: 8673104

4

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

Jooss K, Yang Y, Wilson JM. Jooss K, et al. Hum Gene Ther. 1996 Aug 20;7(13):1555-66. doi: 10.1089/hum.1996.7.13-1555. Hum Gene Ther. 1996. PMID: 8864756

5

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.

Jooss K, Yang Y, Fisher KJ, Wilson JM. Jooss K, et al. J Virol. 1998 May;72(5):4212-23. doi: 10.1128/JVI.72.5.4212-4223.1998. J Virol. 1998. PMID: 9557710 Free PMC article.

6

Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.

Jooss K, Turka LA, Wilson JM. Jooss K, et al. Gene Ther. 1998 Mar;5(3):309-19. doi: 10.1038/sj.gt.3300595. Gene Ther. 1998. PMID: 9614550

7

Recombinant adeno-associated virus for muscle directed gene therapy.

Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K, Pathak R, Raper SE, Wilson JM. Fisher KJ, et al. Among authors: jooss k. Nat Med. 1997 Mar;3(3):306-12. doi: 10.1038/nm0397-306. Nat Med. 1997. PMID: 9055858

8

Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.

Sarukhan A, Camugli S, Gjata B, von Boehmer H, Danos O, Jooss K. Sarukhan A, et al. Among authors: jooss k. J Virol. 2001 Jan;75(1):269-77. doi: 10.1128/JVI.75.1.269-277.2001. J Virol. 2001. PMID: 11119597 Free PMC article.

9

Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.

Robinson M, Li B, Ge Y, Ko D, Yendluri S, Harding T, VanRoey M, Spindler KR, Jooss K. Robinson M, et al. Among authors: jooss k. J Virol. 2009 Apr;83(8):3450-62. doi: 10.1128/JVI.02561-08. Epub 2009 Feb 4. J Virol. 2009. PMID: 19193803 Free PMC article.

10

Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.

Jooss K, Chirmule N. Jooss K, et al. Gene Ther. 2003 Jun;10(11):955-63. doi: 10.1038/sj.gt.3302037. Gene Ther. 2003. PMID: 12756416 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters